Annual Operating Margin
-14.51 K%
-10.87 K%-298.62%
31 December 2023
Summary:
Spyre Therapeutics annual operating profit margin is currently -14.51 thousand%, with the most recent change of -10.87 thousand% (-298.62%) on 31 December 2023. During the last 3 years, it has fallen by -14.16 thousand% (-4041.98%). SYRE annual operating margin is now -7703.50% below its all-time high of -185.95%, reached on 01 December 2015.SYRE Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
N/A
30 September 2024
Summary:
Spyre Therapeutics quarterly operating profit margin is not available.SYRE Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -4042.0% | - |
| 5 y5 years | - | - |
SYRE Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4042.0% | at low | ||
| 5 y | 5 years | -4042.0% | at low | ||
| alltime | all time | -7703.5% | at low |
Spyre Therapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -14.51 K%(+298.6%) | - |
| June 2023 | - | -4180.23%(-56.0%) |
| Mar 2023 | - | -9497.98%(-16.7%) |
| Dec 2022 | -3640.23%(+939.1%) | - |
| Dec 2022 | - | -11.41 K%(+5.8%) |
| Sept 2022 | - | -10.78 K%(+200.4%) |
| June 2022 | - | -3587.68%(+99.9%) |
| Mar 2022 | - | -1794.49%(+219.9%) |
| Dec 2021 | -350.33%(-70.0%) | -560.98%(-61.3%) |
| Sept 2021 | - | -1450.54%(+2862.7%) |
| June 2021 | - | -48.96%(-88.0%) |
| Dec 2018 | -1169.32% | - |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | -406.64%(-25.5%) |
| Mar 2018 | - | -546.03%(+22.1%) |
| Dec 2017 | -531.72%(+12.3%) | -447.10%(-29.5%) |
| Sept 2017 | - | -634.26%(+39.6%) |
| June 2017 | - | -454.36%(-29.5%) |
| Mar 2017 | - | -644.70%(+45.0%) |
| Dec 2016 | -473.34%(+154.6%) | -444.51%(-18.9%) |
| Sept 2016 | - | -548.39%(+37.0%) |
| June 2016 | - | -400.22%(-24.7%) |
| Mar 2016 | - | -531.66%(+110.8%) |
| Dec 2015 | -185.95% | -252.18%(-20.8%) |
| Sept 2015 | - | -318.45%(+662.0%) |
| June 2015 | - | -41.79% |
FAQ
- What is Spyre Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Spyre Therapeutics?
- What is the all time high quarterly operating margin for Spyre Therapeutics?
What is Spyre Therapeutics annual operating profit margin?
The current annual operating margin of SYRE is -14.51 K%
What is the all time high annual operating margin for Spyre Therapeutics?
Spyre Therapeutics all-time high annual operating profit margin is -185.95%
What is the all time high quarterly operating margin for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly operating profit margin is -41.79%